E.A. Grigorenko, S. Kibira, O.O. Rummo, N.P. Mitkovskaya
Belarusian State Medical University, Minsk, Republic of Belarus, Akita University, Akita, Japan, Minsk Scientific and Practical Center of Surgery, Transplantation and Hematology, Minsk, Republic of Belarus
Objective: to determine structural and functional characteristics of the heart in patients with chronic terminal hepatopathy in need of transplantation and their dynamics in liver transplant recipients in the postoperative period.
ключевые слова: chronic terminal hepatopathy, liver transplantation, risk factors for coronary atherosclerosis, cirrhotic cardiomyopathy, diastolic dysfunction

для цитирования: E.A. Grigorenko, S.Kibira, O.O. Rummo, N.P. Mitkovskaya. Myocardial Remodeling and Liver Transplantation: the Results of Prospective Single-Center Study. Emergency Cardiology and CardiovascularRisks. 2018, vol. 2, № 2, pp. 347-357

Myocardial remodeling and liver transplantation: the results of prospective single-center study
E.A. Grigorenko, S. Kibira, O.O. Rummo, N.P. Mitkovskaya
Objective: to determine structural and functional characteristics of the heart in patients with chronic terminal hepatopathy in need of transplantation and their dynamics in liver transplant recipients in the postoperative period.
keywords: chronic terminal hepatopathy, liver transplantation, risk factors for coronary atherosclerosis, cirrhotic cardiomyopathy, diastolic dysfunction

for references: E.A. Grigorenko, S.Kibira, O.O. Rummo, N.P. Mitkovskaya. Myocardial Remodeling and Liver Transplantation: the Results of Prospective Single-Center Study. Emergency Cardiology and CardiovascularRisks. 2018, vol. 2, № 2, pp. 347-357

[1] D’Amico G., Garcia-Tsao G., Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol, 2016, vol. 44, № 1, pp. 217-231.
[2] Al Hamoudi W., Lee S.S. Cirrhotic cardiomyopathy. Ann Hepatol, 2005, vol. 5, № 3, pp. 132-139.
[3] Gaskari S.A., Honar H., Lee S.S. Therapy insight: Cirrhotic cardiomyopathy. Nat Clin Pract Gastroenterol Hepatol, 2006, vol. 3, № 6, pp. 329-337.
[4] Liu H., Lee S.S. What happens to cirrhotic cardiomyopathy after liver transplantation? Hepatology, 2015, vol. 42, № 5, pp. 1203-1205.
[5] Myers R.P., Lee S.S. Cirrhotic cardiomyopathy and liver transplantation. Liver Transpl 2010, vol. 6, Suppl. 1, pp. 44-52.
[6] Therapondos G., Flapan A.D., Plevris J.N., Hayes P.C. Cardiac morbidity and mortality related to orthotopic liver transplantation. Liver Transpl, 2004, vol. 10, № 12, pp. 1441-1453.
[7] Moller S., Henriksen J.H. Cardiovascular dysfunction in cirrhosis: pathophysiological evidence of a cirrhotic cardiomyopathy. Scand J Gastroenterol, 2001, vol. 36, pp. 785-794.
[8] Kim M.Y., Baik S.K. Cirrhotic cardiomyopathy. Korean J Hepatol, 2007, vol. 13, № 1, pp. P. 20-26.
[9] Cazzaniga M., Salerno F., Pagnozzi G., Dionigi E., Visentin S., Cirello I., Meregaglia D., Nicolini A. Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt. Gut, 2007, vol. 56, № 6, pp. 869-875.
[10] Moller S., Henriksen J.H. Cardiovascular complications of cirrhosis. Gut, 2008, vol. 57, № 2, pp. 268-278.
[11] Liu H., Gaskari S.A., Lee S.S. Cardiac and vascular changes in cirrhosis: pathogenic mechanisms. World J Gastroenterol, 2006, vol. 12, № 6, pp. 837-842.
Формат файла: pdf (1.15 Мб)